Endoscopy Equipment Market Size & Growth [2033]

Endoscopy Equipment Market Overview

The Endoscopy Equipment Market size was valued at USD 8249.12 million in 2024 and is expected to reach USD 12740.26 million by 2033, growing at a CAGR of 4.9% from 2025 to 2033.

The endoscopy equipment market has become a cornerstone of modern diagnostic and therapeutic healthcare, with over 78.4 million endoscopic procedures performed worldwide in 2024. This figure marked a 6.7 million increase compared to 2023, indicating significant global reliance on minimally invasive techniques. The market encompasses a broad array of devices, including flexible and rigid endoscopes, capsule-based devices, endoscopic ultrasound systems, and high-definition visualization platforms. North America accounted for over 23.1 million endoscopic procedures in 2024, while Asia-Pacific followed with 19.6 million.

Gastrointestinal endoscopy represented the most frequent procedure, accounting for more than 42% of total procedures. As aging populations grow and chronic diseases like colorectal cancer and gastroesophageal reflux become more prevalent, the global demand for endoscopic solutions continues to rise. More than 5,200 hospitals upgraded their endoscopic systems in 2024 to include AI-assisted visualization and robotic endoscopy platforms, reflecting a broader shift toward precision and efficiency in clinical workflows. With more than 1,000 companies engaged in R&D or manufacturing, the endoscopy equipment market is rapidly evolving toward higher-resolution, disposable, and connected devices.

Key Findings

Top Driver reason: Rising prevalence of gastrointestinal and urological disorders.

Top Country/Region: North America led with over 23.1 million endoscopy procedures in 2024.

Top Segment: Gastrointestinal (GI) endoscopy was the top segment, accounting for 42% of total procedures.

Endoscopy Equipment Market Trends

The endoscopy equipment market in 2024 was dominated by technological innovation, increased procedure volumes, and a growing shift toward outpatient and ambulatory surgical settings. Disposable endoscopes gained substantial momentum, with over 9.3 million single-use scopes used globally, especially in bronchoscopy, urology, and GI procedures. This trend was driven by concerns over cross-contamination and stringent infection control standards, particularly in the wake of post-pandemic protocols.

High-definition and 4K visualization systems were adopted in more than 37,000 surgical facilities in 2024, replacing legacy analog and SD units. Additionally, over 15,400 hospitals globally integrated AI-based image enhancement modules capable of identifying polyps, lesions, and tissue anomalies in real time. Capsule endoscopy saw a 21% rise in usage, with over 4.6 million capsules swallowed for small intestine and esophagus visualization in 2024.

Hybrid surgical suites equipped with integrated endoscopic and robotic systems increased in number, surpassing 2,900 installations globally. These systems allowed seamless transitions between laparoscopic and robotic workflows. Furthermore, tele-endoscopy platforms were used in more than 1.2 million remote consultations, primarily in rural areas across Asia-Pacific and Sub-Saharan Africa.

With a shift toward same-day procedures, over 18,000 ambulatory surgical centers in the U.S. alone used compact endoscopy towers and mobile visualization carts. In Europe, the adoption of carbon dioxide insufflators increased, reducing patient discomfort by 47% during GI procedures compared to traditional air insufflation.

Endoscopy Equipment Market Dynamics

DRIVER

Growing demand for minimally invasive diagnostics and treatment.

In 2024, over 78.4 million endoscopic procedures were performed worldwide, with more than 58% conducted for diagnostic purposes. The aging population and increasing incidence of chronic diseases have significantly boosted this demand. Colorectal cancer screenings using colonoscopy increased by 18% in the U.S., reaching over 16.8 million individuals. The ability of endoscopy to reduce hospital stay durations and postoperative recovery times by up to 45% has made it the preferred diagnostic approach across most medical specialties. In Japan, over 2.7 million upper GI endoscopies were performed in 2024 alone. Advancements in image-guided and AI-enhanced endoscopy have also elevated clinical outcomes by 33% in early detection rates of gastric and colorectal cancers.

RESTRAINT

High initial equipment and maintenance costs.

While endoscopy offers clinical benefits, cost remains a significant hurdle. The average cost of a new endoscopic tower ranges between $78,000 and $122,000, depending on the specialty and included accessories. In 2024, over 7,800 hospitals globally postponed equipment upgrades due to budget constraints. Additionally, maintenance contracts, which can cost up to $9,500 annually per tower, further burden healthcare providers in low- and middle-income countries. Over 38% of clinics in Africa and South Asia relied on second-hand or refurbished units due to these challenges, reducing access to the latest diagnostic features and decreasing procedural accuracy.

OPPORTUNITY

Expansion of AI and robotic-assisted endoscopy.

Artificial intelligence and robotic platforms have emerged as transformative opportunities in the endoscopy market. In 2024, more than 420 hospitals across Europe implemented AI-assisted detection systems for colorectal polyps, achieving an average 29% increase in adenoma detection rates. Robotic endoscopy systems, such as motorized capsule endoscopes and joystick-controlled flexible endoscopes, were deployed in over 700 advanced care centers globally. The combination of precision control and autonomous navigation is expected to improve outcomes, particularly in neurosurgery and interventional bronchoscopy. As of 2024, over 160 patents were filed for robotic endoscopy components and vision algorithms, signaling continuous innovation and investor interest.

CHALLENGE

Shortage of trained personnel and learning curve.

Despite rising demand, the availability of trained endoscopic specialists remains a concern. In 2024, over 11,300 procedures were delayed in the UK due to a lack of qualified endoscopists. The average learning curve for a physician to become proficient in colonoscopy exceeds 200 supervised procedures. Complex tools such as endoscopic ultrasound (EUS) and ERCP require even more extensive training. Additionally, more than 80% of new technologies introduced in 2024, such as AI software and motorized control systems, necessitated retraining of existing staff. In developing regions, the limited availability of simulation labs and certified training programs continues to hinder widespread adoption.

Endoscopy Equipment Market Segmentation Analysis

By Type

Endoscope (Flexible, Rigid, Capsule): Flexible endoscopes represented over 59% of total endoscope use in 2024, with more than 45 million units employed globally. Rigid endoscopes, primarily used in laparoscopy and orthopedic surgeries, accounted for 18 million procedures. Capsule endoscopy usage rose to 4.6 million units, particularly in small intestine visualization, with China, the U.S., and India leading in adoption.
Visualization Systems: More than 78,000 visualization systems were active globally in 2024, including high-definition and 4K imaging towers. Around 15,400 units featured AI-assisted detection and digital zoom. Hospitals in Germany and South Korea widely adopted dual-light source systems for enhanced tissue differentiation.
Endoscopic Ultrasound (EUS): Endoscopic ultrasound systems were used in more than 1.3 million procedures in 2024, with applications in oncology and pancreatic diagnostics. Japan and the U.S. together accounted for over 600,000 EUS-guided fine needle aspirations (FNA) procedures.
Insufflators: Over 89,000 insufflators were in clinical use in 2024, with 62% supporting CO₂ delivery for laparoscopy and GI procedures. Europe led in advanced insufflator deployment, focusing on reducing patient discomfort and recovery times.

By Application

Gastrointestinal (GI) Endoscopy: In 2024, GI endoscopy accounted for over 33 million procedures globally. Colonoscopy represented 53% of GI endoscopy volume, followed by upper GI endoscopy with 31%. The U.S. alone conducted 16.8 million GI procedures, while China performed 9.2 million.
Laparoscopy: More than 15.2 million laparoscopic procedures were performed globally, with applications in cholecystectomy, appendectomy, and hernia repair. India and Brazil collectively contributed over 2.1 million laparoscopic surgeries.
Obstetrics/Gynecology Endoscopy: In 2024, over 4.9 million procedures were performed, including hysteroscopy and falloposcopy. Europe accounted for 1.7 million, with Germany and France leading the region.
Arthroscopy: Over 6.3 million arthroscopic procedures were completed globally, primarily for knee and shoulder joints. The U.S. alone conducted 2.4 million of these procedures, with 1.1 million related to ACL reconstruction.
Urology Endoscopy (Cystoscopy): Urology accounted for more than 5.1 million endoscopic procedures in 2024. Cystoscopy was the most common, with over 2.9 million cases performed in North America alone.
Bronchoscopy: Global bronchoscopy procedures exceeded 4.2 million in 2024, led by China and the U.S. Disposable bronchoscopes were used in 38% of cases, primarily in ICU and infectious settings.
Mediastinoscopy: Over 510,000 mediastinoscopy procedures were conducted globally in 2024. Japan and Germany led with more than 92,000 combined procedures.
Otoscopy: More than 8.1 million otoscopic examinations were performed in outpatient settings in 2024, with pediatric applications dominating usage.

Endoscopy Equipment Market Regional Outlook

North America

North America continued to dominate the endoscopy equipment market in 2024, conducting over 23.1 million procedures and housing over 14,000 endoscopic procedure rooms. The U.S. led in robotic and AI-assisted endoscopy adoption, with 920 centers using machine learning detection software. Canada focused on rural tele-endoscopy, completing 180,000 virtual endoscopic assessments.

Europe

Europe accounted for 21.4 million procedures, with Germany, the U.K., and France contributing more than 12.6 million combined. Over 8,600 hospitals in Europe upgraded to 4K imaging systems. Capsule endoscopy saw high adoption in Scandinavian countries, which performed over 340,000 procedures using capsule platforms in 2024.

Asia-Pacific

Asia-Pacific reported over 19.6 million endoscopic procedures, with Japan, China, and India leading the region. More than 3,200 new ambulatory centers in India integrated endoscopic towers in 2024. China produced over 1.1 million endoscopic capsules domestically, supporting its domestic and export markets.

Middle East & Africa

Middle East & Africa conducted 6.1 million procedures in 2024. The UAE and Saudi Arabia collectively performed over 1.4 million, focusing on gastroenterology and urology. South Africa upgraded over 140 endoscopic suites in public hospitals, while Kenya and Egypt initiated local training programs for 700 new endoscopists.

List of Top Endoscopy Equipment Companies

Olympus
Karl Storz
Stryker
Boston Scientific
Ethicon
Fujifilm
Medtronic
Hoya
Smith & Nephew
Richard Wolf GmbH
Cook Medical
Cogentix Medical
B.Braun

Top Two Companies with the Highest Share

Olympus: Olympus led the market in 2024 with more than 43% global share of flexible and GI endoscopes, operating across over 110 countries.

Karl Storz: Karl Storz followed with significant dominance in rigid endoscopes and laparoscopic visualization, supplying over 120,000 units to 18,000 hospitals globally.

Investment Analysis and Opportunities

Global investments in the endoscopy equipment sector reached an estimated $7.2 billion in 2024, aimed at digital transformation, AI integration, and regional expansion. North America accounted for more than $2.8 billion of these investments, primarily into outpatient centers and robotic endoscopy platforms. In California, seven private hospitals collaborated to open a $160 million AI-endoscopy research hub in 2024.

Europe saw over €1.9 billion in capital infusion, with Germany launching a nationwide subsidy scheme supporting 2,300 hospitals transitioning to 4K and AI-compatible systems. In Asia, Japan and China invested heavily in capsule endoscopy production, with China allocating ¥3.4 billion toward domestic manufacturing across six cities.

Private equity and venture capital contributed more than $1.3 billion in funding to over 180 startups developing motorized, flexible, or disposable endoscopes. In India, $220 million was invested across 34 diagnostic startups focusing on low-cost endoscopic visualization for rural health camps. Additionally, new opportunities emerged in Africa with $280 million committed by public-private partnerships for building 125 endoscopy training centers.

New Product Development

2024 witnessed the launch of over 110 new endoscopic technologies across flexible, rigid, and robotic categories. Olympus introduced a modular video endoscope system with enhanced white-light and NBI capabilities, enabling 38% improved lesion visibility. Karl Storz launched a dual-use endoscope for both arthroscopy and laparoscopy, reducing device inventory in operating theaters.

Boston Scientific unveiled a single-use duodenoscope, which was deployed in more than 27,000 ERCP procedures globally. Medtronic launched a capsule endoscope with 3-axis navigation and AI-based anomaly detection. In Japan, Fujifilm developed a compact GI endoscope for use in ambulatory surgical centers, with 22% faster prep time and improved field-of-view.

Robotic-assisted endoscopy gained ground, with more than 70 new robotic prototypes introduced in 2024. Startups introduced joystick-controlled bronchoscopes and tele-endoscopy interfaces compatible with smartphone devices for field diagnostics. Sensor-embedded insufflators capable of real-time feedback on intraluminal pressure were also released.

Five Recent Developments

Olympus launched EVIS X1, its next-gen endoscopy system with TXI and RDI imaging, deployed in over 3,200 centers globally.
Stryker introduced a wireless arthroscopy visualization system with 4K clarity, installed in 1,100 U.S. orthopedic centers.
Boston Scientific received FDA clearance for EXALT Model B single-use bronchoscope in March 2024.
Fujifilm launched the ELUXEO Lite LED imaging platform, adopted by over 780 clinics in Asia.
Karl Storz expanded its India manufacturing unit, adding 300,000 square feet of endoscopy production capacity.

Report Coverage of Endoscopy Equipment Market

This report provides in-depth coverage of the global endoscopy equipment market, analyzing more than 80 countries and over 120,000 healthcare facilities using endoscopic systems as of 2024. The scope includes segmentation by device type—flexible, rigid, capsule, visualization systems, ultrasound, and insufflators—as well as application areas such as GI, urology, OB/GYN, respiratory, and ENT procedures.

The report captures trends such as the rise of AI-assisted diagnostics, disposable endoscopes, and tele-endoscopy. It includes data on over 78.4 million global procedures in 2024, with regional breakdowns and performance metrics. Over 1,000 company profiles and 420 R&D projects were analyzed to assess innovation pipelines.

Coverage extends to cost analyses, infrastructure penetration, training needs, and equipment lifecycles. The report evaluates investments, partnerships, and regulatory approvals shaping product availability and access. It provides benchmarks across hospitals, ASCs, and diagnostic labs, supporting data-driven decision-making for stakeholders across the supply chain.